Pleased to share our new ENOTTA publication “Therapeutic Drug Monitoring guided vedolizumab treatment in ulcerative colitis in Cyprus: a cost-effectiveness analysis.”
The paper explores how Therapeutic Drug Monitoring (TDM) can change the treatment landscape. Our analysis suggests that TDM-guided VDZ dose optimization may not only improve clinical responses but also significantly reduce the need for surgery, proving to be a cost-effective strategy in Cyprus.
This publication is the proud result of a Short-Term Scientific Mission (STSM) and a fantastic collaborative effort by members of the ENOTTA network!
👏 Huge congratulations to our Members: Olga Pitsillidou, Panagiotis Petrou, Petya Milushewa, Maria Pitsillidou, Elli Filippou, and Sean Gavan P. Gavan.
🔗 Read the full analysis in Value in Health here
#HealthEconomics #UlcerativeColitis #TherapeuticDrugMonitoring #TDM #ENOTTA #CostEffectiveness #ValueInHealth #Pharmacoeconomics #Gastroenterology #STSM #ResearchCollaboration
New Publication from ENOTTA
